3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
Evidence-based guide to Belsomra (suvorexant) dose escalation. Covers FDA-approved titration steps, accelerated timelines, and monitoring considerations for suvorexant titration, with a clinician-discussion and monitoring framework.
Belsomra dosing starts at 10mg, ranges 5-20mg. Titrate up after 7 days if ineffective; 20mg is the FDA-labeled maximum dose for adults.
A guide to the FDA-approved Belsomra (suvorexant) titration schedule, covering starting doses, escalation timing, special populations, and real-world dosing evidence.